• O NAMA

Welcome

Forgot password?

Not a member? Join today

Logo
  • Početna
  • Bolesti
    • Hronična limfocitna leukemija
    • Non hočkinski limfom
    • Hočkinski limfom
    • Leukemije
      • AML
      • ALL
  • Edukacija
    • Prezentacije
      • HLL
      • NHL
      • HL
    • Kvizovi
      • HLL
      • NHL
      • HL
  • Stil života
    • Zdraviji recepti
    • Fizička aktivnost
    • Prevencija
    • Korisni saveti
  • Resursi
    • Video
    • Brošure
    • Infografike
  • Blog
  • English
  • Početna
  • Bolesti
    • Hronična limfocitna leukemija
    • Non hočkinski limfom
    • Hočkinski limfom
    • Leukemije
      • AML
      • ALL
  • Edukacija
    • Prezentacije
      • HLL
      • NHL
      • HL
    • Kvizovi
      • HLL
      • NHL
      • HL
  • Stil života
    • Zdraviji recepti
    • Fizička aktivnost
    • Prevencija
    • Korisni saveti
  • Resursi
    • Video
    • Brošure
    • Infografike
  • Blog
  • English

Počelo istraživanje koje je dizajnirano da istraži potrebe pacijenata sa hroničnom limfocitnom leukemijom (HLL) u Evropi

30 Aug 2017
  • maja
  • Uncategorized

Počelo istraživanje koje je dizajnirano da istraži potrebe pacijenata sa hroničnom limfocitnom leukemijom (HLL) u Evropi

Udruženje LIPA podržava istraživanje na prostoru cele Evrope koje je dizajnirano da istraži potrebe pacijenata sa hroničnom limfocitnom

Read More

30 Aug 2017
  • maja
  • Hočkinov limfom

Management and controversies of classical Hodgkin lymphoma in pregnancy

Management and controversies of classical Hodgkin lymphoma in pregnancy The goal of managing classical Hodgkin lymphoma (cHL) in pregnancy is to

Read More

30 Aug 2017
  • maja
  • Hočkinov limfom

Risk of central nervous system relapse in non-Hodgkin lymphoma patients treated with EPOCH-R

Risk of central nervous system relapse in non-Hodgkin lymphoma patients treated with EPOCH-R The authors looked at relapses that occur in the

Read More

13 Aug 2017
  • maja
  • Hronična limfocitna leukemija

The benefits of combining antibody treatment and chemotherapy for previously untreated CLL patients

The benefits of combining antibody treatment and chemotherapy for previously untreated CLL patients This study compared the effectiveness of

Read More

13 Aug 2017
  • maja
  • Hronična limfocitna leukemija

Comparing genetic abnormalities and outcomes of CLL and monoclonal B-Cell lymphocytosis

Comparing genetic abnormalities and outcomes of CLL and monoclonal B-Cell lymphocytosis This study examined genetic abnormalities monoclonal

Read More

  • 1
  • 2
  • 3
  • 4
  • 5

Izradu platforme podržala kompanija

KONTAKT

Udruženje LIPA
+ 381 60 0 222 317
majaklipa@gmail.com
www.lipa.org.rs

Budite u toku sa najnovijim dešavanjima. Prijavite se

© Copyright LIPA 2017